DiogenX
Entity

  • DiogenX

    Created in 2020
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    1,302

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    13002 Marseille, France

    Marseille

    France

  • Employees

    Scale: 2-10

    Estimated: 12

  • SIREN

    881305544

  • Engaged corporates

    4
    2 3

  • Added in Motherbase

    10 months, 4 weeks ago
Description
  • Value proposition

    Targeting Beta Cell recovery in Diabetes

    DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world.
    Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits.
    DiogenX is headquartered in Marseille, with labs in Nice (France).



    Biotechnology and Diabetes

  • Original language

    Targeting Beta Cell recovery in Diabetes

    DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world.
    Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits.
    DiogenX is headquartered in Marseille, with labs in Nice (France).

Corporate interactions BETA
Corporate TypeTweets Articles
CNRS Innovation
CNRS Innovation
Research, Research Services
CNRS Innovation
Research, Research Services 		Other

7 Mar 2024


Omnes
Omnes
Startup accelerator & VC, Financial Services
Omnes
Startup accelerator & VC, Financial Services 		Other

21 Dec 2023


Roche
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Roche
Pharmaceutical, Biotechnology, Biotechnology Research 		Other

30 Oct 2023


Boehringer Ingelheim
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health 		Other

30 Oct 2023


Similar entities
Last news
Show all articles
Social network dynamics